Search clinical trials for: Meloxicam 3.75 mg

Total 11121 results

Boehringer Ingelheim

Completed

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

Pain
Boehringer Ingelheim

Completed

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

Dysmenorrhea
Abbott
Fraktal.com.pl; Med-net.pl

Completed

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) (LEMON)

Lower Urinary Tract Symptoms | Advanced Prostate Cancer

Poland, Ukraine
Boehringer Ingelheim

Completed

A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)

Arthritis, Juvenile Rheumatoid

Belgium, Italy, Germany, Russian Federation, France, Austria, United Kingdom
Cytokinetics

Completed

Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction

Heart Failure With Reduced Ejection Fraction

Japan
AbbVie (prior sponsor, Abbott)

Completed

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Diabetic Nephropathy | Chronic Kidney Disease

United States, Puerto Rico
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Fasting Conditions

Healthy

Canada
Yonsei University

Completed

Comparative Study of Two Multifocal Intraocular Lens With Different Add Power

Cataract

Korea, Republic of
Solvay Pharmaceuticals

Completed

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects

Atrial Fibrillation | Atrial Flutter

Russian Federation, Romania, United States, Argentina, Czech Republic, Former Serbia and Montenegro, Germany, Israel, Poland, Slovakia, South Africa, Ukraine, United Kingdom
Joseph Mccune
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases (LUPRON)

Lupus Erythematosus, Systemic | Systemic Vasculitis | Lung Disease With Systemic Sclerosis | Isolated Angiitis of Central Nervous System | Lung Disease Interstitial Diffuse

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Hypertension

United States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
Cytokinetics

Completed

A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

Intermittent Claudication | Peripheral Artery Disease

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg

Healthy

United States
Teva Pharmaceuticals USA

Completed

Meloxicam 15 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
ReveraGen BioPharma, Inc.
University of Pittsburgh; Cooperative International Neuromuscular Research...

Completed

Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada, United Kingdom, Sweden, Australia, Israel
Janssen Research & Development, LLC

Completed

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age (CADMUS Jr)

Psoriasis

United States, Germany, Taiwan, Belgium, Korea, Republic of, Canada, Poland, Hungary, Netherlands
ReveraGen BioPharma, Inc.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada, United Kingdom, Sweden, Australia, Israel
ReveraGen BioPharma, Inc.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada, United Kingdom, Sweden, Australia, Israel
Boehringer Ingelheim

Completed

Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

Pharyngitis
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

HPPH Photodynamic Therapy for Patients With Esophageal Cancer (HPPH)

Esophageal Cancer

China
Boehringer Ingelheim

Completed

Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers

Healthy
VA Office of Research and Development

Completed

Discontinuing NSAIDs in Veterans With Knee Osteoarthritis

Knee Osteoarthritis

United States
Boehringer Ingelheim

Completed

Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers

Healthy
Baptist Health South Florida

Recruiting

ZYNRELEF for Pain Management in Total Knee Arthroplasty

Osteoarthritis, Knee | Post Operative Pain

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects

Healthy
British University In Egypt
Ain Shams University

Unknown

A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin.

Hepatitis C

Egypt
Boehringer Ingelheim

Completed

A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

China
Boehringer Ingelheim

Completed

Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range

Healthy
Boehringer Ingelheim

Completed

A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis

Osteoarthritis

China
Iroko Pharmaceuticals, LLC

Withdrawn

Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain

Osteoarthritis
Alfarabi Colleges

Completed

Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block

Symptomatic Irreversible Pulpitis

Saudi Arabia
Boehringer Ingelheim

Completed

Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects

Healthy
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; eCardio Diagnostics

Completed

Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation

Atrial Fibrillation

United States
VA Quality Enhancement Research Intiative

Withdrawn

Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot (MELODY)

Chronic Obstructive Pulmonary Disease | Emphysema | COPD | Chronic Bronchitis | Dyspnea | Breathlessness

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NRX-1074)

Major Depressive Disorder

United States
Laboratorios Andromaco S.A.
Instituto Chileno de Medicina Reproductiva

Completed

Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women

Contraception | Bleeding Pattern

Chile
Boehringer Ingelheim

Completed

Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects

Healthy
Beijing Tide Pharmaceutical Co., Ltd
The Third Xiangya Hospital of Central South University

Not yet recruiting

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

Pain, Post-operative

China
Boehringer Ingelheim

Completed

A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets

Healthy

Russian Federation
Javelin Pharmaceuticals

Completed

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Hallux Valgus
Karadeniz Technical University

Completed

The Effect of Singing or Playing Melodica in COPD Patients (COPD)

Chronic Obstructive Pulmonary Disease

Turkey
Kecioren Education and Training Hospital

Completed

Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

Asthma

Turkey
Pharma Two B Ltd.

Completed

A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

Parkinson Disease | Early Parkinson's Disease

United States, Canada, Germany, Spain
Colorado Center for Reproductive Medicine
AbbVie

Active, not recruiting

Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis

Infertility | Endometriosis

United States
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
Rothman Institute Orthopaedics

Enrolling by invitation

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

Shoulder Pain

United States
Rothman Institute Orthopaedics

Enrolling by invitation

Pain Relief After PrimaryTKA

Pain, Postoperative

United States
Centre Hospitalier Universitaire de Besancon

Completed

Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid Endarterectomy (CERVECHO) (CERVECHO)

Carotid Atherosclerosis | Regional Anaesthesia Morbidity

France
Boehringer Ingelheim

Completed

Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis

Spondylitis, Ankylosing

Search clinical trials for: Meloxicam 3.75 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations